Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60

By sjmartinez • April 23, 2024

Egeberg A, Hawkes JE, Somani N, Burge R, See K, Gallo G, McKean-Matthews M, Gooderham M, Han G, Armstrong A. Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60. Dermatol Ther (Heidelb). 2024 Apr 22. doi: 10.1007/s13555-024-01147-7. Epub ahead of print. PMID: 38647975.

Tags: Clinical outcomes, Dermatology, ixekizumab, long-term, patient-reported outcomes, psoriasis, Publications, Quality of Life, Scalp clearance

Evaluation and Treatment of Elevated Bile Acids in Chronic Pruritus of the Elderly: A Case Series

Truong A, Schoettinger K, Kaffenberger BH, Milani-Nejad N. Evaluation and Treatment of Elevated Bile Acids in Chronic Pruritus of the Elderly: A Case Series. Int[...]

Artificial Intelligence in Patch Testing: Comprehensive Review of Current Applications and Future Prospects in Dermatology

Tang HS, Ebriani J, Yan MJ, Wongvibulsin S, Farshchian M. Artificial Intelligence in Patch Testing: Comprehensive Review of Current Applications and Future Prospects in Dermatology.[...]

MicroBayesAge: a maximum likelihood approach to predict epigenetic age using microarray data

Nolan N, Mitchell M, Mboning L, Bouchard LS, Pellegrini M. MicroBayesAge: a maximum likelihood approach to predict epigenetic age using microarray data. Geroscience. 2025 May[...]